Ón Dec. 12, 2022, the American Diabetes Association (ADA) published Standards of Care in Diabetes—2023 (Standards of Care). These are comprehensive, evidence-based guidelines for the prevention, diagnosis, and treatment of diabetes.

Ahead of World Diabetes Day 2022 (Nov. 14), P&G Health, announced its 'Put Life Back in Your Hands' campaign being commemorated across 18 countries in Asia Pacific, Middle East, and Africa, to raise public awareness on the connection between Peripheral Neuropathy and Diabetes, and the importance of early identification and timely treatment.

Podiatrists are concerned about the growing prevalence of diabetes among Asian Americans and are sending a clear message, especially to Asian American women: It's time to start taking care of your diabetes. Foot and ankle surgeons say sociocultural factors among Asian Americans lead many women to devote themselves to their families to the detriment of their own health.

A new food modeling substitution study published in Current Developments In Nutrition1 shows how 98% of adult Americans could eat a more Mediterranean-Style Diet by making just three recipe swaps in their diet that includes honey paired with olive oil on leafy greens with fruit, on whole grains and on fish2.

One the many unhealthy outcomes of America's state of obesity occurs when people start building up excess fat around their liver, a condition called non-alcoholic fatty liver disease (NAFLD).

One Drop announced analyses from a randomized control trial (RCT) on the impact of its digital health platform on workplace productivity among people with type 2 diabetes, published in the Journal of Occupational Environmental Medicine (JOEM).

The American Association of Kidney Patients (AAKP), the largest independent kidney patient organization in the USA, and its strategic partners at The George Washington University School of Medicine & Health Sciences (SMHS) hosted their 4th Annual Global Summit on Kidney Innovations, titled "Global Kidney Patient Voice™ - The Key to Accelerating Innovations," on August 23-24, 2022.

 AltrixBio, an emerging early-stage biotech startup, is presenting an abstract on LuCI™, a repurposed pill that adheres to the gastrointestinal (GI) tract for controlled GI targeting. The solution is derived from the work of leading specialists at Brigham and Women's Hospital and Harvard Medical School, working with patients presenting with Type 2 Diabetes (T2D) and obesity.